Cargando…

Respiratory syncytial virus reinfections among infants and young children in the United States, 2011–2019

BACKGROUND: Although respiratory syncytial virus (RSV) immunoprophylaxis is recommended for high-risk infants, the American Academy of Pediatrics (AAP) recommends against immunoprophylaxis in the same season following a breakthrough hospitalization due to limited risk for a second hospitalization. E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nduaguba, Sabina O., Tran, Phuong T., Choi, Yoonyoung, Winterstein, Almut G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934310/ https://www.ncbi.nlm.nih.gov/pubmed/36795639 http://dx.doi.org/10.1371/journal.pone.0281555

Ejemplares similares

RSV testing practice and positivity by patient demographics in the United States: integrated analyses of MarketScan and NREVSS databases
por: Tran, Phuong T., et al.
Publicado: (2022)

Utilization of chronic lung disease treatment before the respiratory syncytial virus season as palivizumab prophylaxis qualifier in the American Academy of Pediatrics Guidelines
por: Choi, Yoonyoung, et al.
Publicado: (2021)

Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017–2019
por: Choi, Yoonyoung, et al.
Publicado: (2021)

Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011–2019
por: Suh, Mina, et al.
Publicado: (2022)

Respiratory Syncytial Virus Activity — United States, July 2011–January 2013
por: Haynes, Amber K., et al.
Publicado: (2013)

The Burden of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Synthesis
por: Simões, Eric A F
Publicado: (2022)

Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009–2019: A Study of the National (Nationwide) Inpatient Sample
por: Suh, Mina, et al.
Publicado: (2022)

Respiratory Syncytial Virus-Associated Hospitalizations in Young Children in the United States, 2015–2016
por: Rha, Brian, et al.
Publicado: (2017)

Respiratory syncytial virus-associated seizures in Korean children, 2011–2016
por: Cha, Teahyen, et al.
Publicado: (2019)

Respiratory syncytial virus in severe lower respiratory infections in previously healthy young Ethiopian infants
por: Weldetsadik, Abate Yeshidinber, et al.
Publicado: (2021)

Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States
por: Parikh, Rohan C., et al.
Publicado: (2017)

The impact of influenza and respiratory syncytial virus on hospitalizations for lower respiratory tract infections in young children: Slovenia, 2006–2011
por: Učakar, Veronika, et al.
Publicado: (2013)

1362. Antibiotic Prescribing for Acute Otitis Media in Commercially Insured Pediatric Patients in the United States
por: Smolinski, Nicole, et al.
Publicado: (2020)

The Natural History of Respiratory Syncytial Virus in a Birth Cohort: The Influence of Age and Previous Infection on Reinfection and Disease
por: Ohuma, E. O., et al.
Publicado: (2012)

2328. Human Respiratory Syncytial Virus Subgroups among Hospitalized Infants in the United States, 2015–2016
por: Rha, Brian, et al.
Publicado: (2019)

1526. The economic impact of respiratory syncytial virus (RSV) in infants in the United States: systematic literature review
por: Bowser, Diana, et al.
Publicado: (2020)

Respiratory Syncytial Virus Resurgence in Italy: The Need to Protect All Neonates and Young Infants
por: Bozzola, Elena
Publicado: (2021)

The disease burden of respiratory syncytial virus in Infants
por: Munro, Alasdair P.S., et al.
Publicado: (2023)

Novel Respiratory Syncytial Virus A Genotype, Germany, 2011–2012
por: Prifert, Christiane, et al.
Publicado: (2013)

RESPIRATORY SYNCYTIAL AND OTHER VIRUSES ASSOCIATED WITH RESPIRATORY DISEASE IN INFANTS
por: Jacobs, J.W., et al.
Publicado: (1971)

Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
por: Jones, Jefferson M., et al.
Publicado: (2023)

Healthcare-associated respiratory syncytial virus infections in children’s hospitals
por: Saiman, Lisa, et al.
Publicado: (2022)

Genetic Relatedness of Infecting and Reinfecting Respiratory Syncytial Virus Strains Identified in a Birth Cohort From Rural Kenya
por: Agoti, Charles N., et al.
Publicado: (2012)

Clinical impact of healthcare-associated respiratory syncytial virus in hospitalized adults
por: Hill-Ricciuti, Alexandra, et al.
Publicado: (2023)

Respiratory Syncytial Virus Outbreak in Infants and Young Children during COVID-19 Pandemic in Taiwan
por: Chi, Hsin, et al.
Publicado: (2023)

Respiratory Syncytial Virus Seasonality — United States, 2014–2017
por: Rose, Erica Billig, et al.
Publicado: (2018)

Seasonality of Respiratory Syncytial Virus — United States, 2017–2023
por: Hamid, Sarah, et al.
Publicado: (2023)

A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom
por: Bentley, Anthony, et al.
Publicado: (2013)

Epidemiology of Respiratory Syncytial Virus Infection in Preterm Infants
por: Resch, Bernhard, et al.
Publicado: (2011)

Respiratory Syncytial Virus Infection in High-Risk Infants
por: Resch, Bernhard
Publicado: (2011)

Detection of respiratory syncytial virus and rhinovirus in healthy infants
por: Hasegawa, Kohei, et al.
Publicado: (2015)

Respiratory syncytial virus infection in infants in rural Nepal
por: Chu, Helen Y., et al.
Publicado: (2016)

Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
por: Fleming-Dutra, Katherine E., et al.
Publicado: (2023)

Prenatal Exposure to Respiratory Syncytial Virus Alters Postnatal Immunity and Airway Smooth Muscle Contractility during Early-Life Reinfections
por: Brown, Paul M., et al.
Publicado: (2017)

Healthcare-Associated Respiratory Syncytial Virus in Children’s Hospitals
por: Saiman, Lisa, et al.
Publicado: (2023)

Respiratory Syncytial Virus Disease: Immunoprophylaxis Policy Review and Public Health Concerns in Preterm and Young Infants
por: Staebler, Suzanne, et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus 2 reinfection in a coronavirus disease 2019 recovered young adult: a case report
por: Awada, Hussein, et al.
Publicado: (2021)

Environmental Drivers of the Spatiotemporal Dynamics of Respiratory Syncytial Virus in the United States
por: Pitzer, Virginia E., et al.
Publicado: (2015)

Respiratory Syncytial Virus — United States, July 2012–June 2014
por: Haynes, Amber K., et al.
Publicado: (2014)

Retrospective Parameter Estimation and Forecast of Respiratory Syncytial Virus in the United States
por: Reis, Julia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mrl4af4ooqn46h55eq8brkpqfm